Real-world patients were on average older and had more comorbidities than those in clinical trials, factors previously seen in comparisons between patients in clinical trials and real-world settings.
The efficacy of treatments, which is the outcomes in the ideal clinical trial setting, are known to often be better than the effectiveness of those treatments, which are the outcomes of patients in the real-world setting.
/PRNewswire/ Four studies presented during the 65th American Society of Hematology (ASH) Annual Meeting and Exposition examine how demographics and other.